Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation

Table 1

Base parameter input to model and ranges of sensitivity analysis.

Parameters	Baseline value	Range	Distribution	Source
Transition probabilities (monthly)
PFS to PD in the 2- to 3-month group	1.18%	0.59–2.36%	Beta
PFS to PD in the 3- to 4-month group	2.51%	1.26–5.02%	Beta
Costs per circle ($)
Two-month group monthly cost	117.16	58.58–234.32	Gamma
Three-month group monthly cost	78.10	39.05–156.20	Gamma
Utility value
Utility PFS	0.76	0.61–0.91	Beta	[15]
Utility PD	0.68	0.54–0.82	Beta	[15]
Discount rate	5%	0%–5%	Fixed	[16]

PD, progressive disease; PFS, progression-free survival.